Bastion Asset Management’s Procept Biorobotics PRCT Stock Holding History

Bastion Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.09M	Buy	+447,131	New	+$8.91M	3.53%	13

Other funds holding PRCT

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Bastion Asset Management's PRCT Position: Q3 2026 in Review

Bastion Asset Management opened a new position in Procept Biorobotics (PRCT) in Q3 2026: 447,131 shares worth $8.09M. The stake represents 3.53% of the portfolio and ranks #13 among its holdings.

89 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

Bastion Asset Management held 447,131 shares of Procept Biorobotics worth $8.09M as of Q3 2026.
Procept Biorobotics was a new Bastion Asset Management position in Q3 2026.
Procept Biorobotics made up 3.53% of Bastion Asset Management's portfolio in Q3 2026, its #13 holding.
89 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Bastion Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.